 
 
EXPLANATION:  CAPITALS INDICATE MAT TER ADDED TO EXISTING LAW . 
        [Brackets ] indicate matter deleted from existing law.  
         Underlining  indicates amendments to bill.  
         Strike out  indicates matter stricken from the bill by amendment or deleted from the law by 
amendment.             *hb1243*      
HOUSE BILL 1243  
J5   5lr2645  
    CF SB 975  
By: Delegate S.  Johnson  Delegates S.  Johnson, Alston, Bagnall , Bhandari, 
Chisholm, Cullison, Guzzone, Hill, Hutchinson, Kaiser, Kerr, Kipke, Lopez, 
Martinez, M.  Morgan, Pena –Melnyk, Reilly, Rosenberg, Ross, Szeliga, 
Taveras, White  Holland, Woods, and Woorman  
Introduced and read first time: February 7, 2025  
Assigne d to: Health and Government Operations  
Committee Report: Favorable with amendments  
House action: Adopted  
Read second time: March 1, 2025  
 
CHAPTER ______  
 
AN ACT concerning  1 
 
Health Insurance – Coverage for Specialty Drugs  2 
 
FOR the purpose of prohibiting certain insurers, nonprofit health service plans, and health 3 
maintenance organizations from excluding coverage for certain specialty drugs that 4 
are administered or dispensed by a provider that meets certain criteria; requiring 5 
the reimbursement  rate for certain specialty drugs to meet certain criteria; and 6 
generally relating to health insurance coverage for specialty drugs.  7 
 
BY repealing and reenacting, without amendments,  8 
 Article – Insurance  9 
Section 15 –847(a)(1) and (5)  10 
 Annotated Code of Ma ryland  11 
 (2017 Replacement Volume and 2024 Supplement)  12 
 
BY repealing and reenacting, with amendments,  13 
 Article – Insurance  14 
Section 15 –847(d), 15 –1611.1, and 15 –1612  15 
 Annotated Code of Maryland  16 
 (2017 Replacement Volume and 2024 Supplement)  17 
 
BY adding to  18 
 Article – Insurance  19 
2 HOUSE BILL 1243   
 
 Section 15–847(h) and  15–847.2  1 
 Annotated Code of Maryland  2 
 (2017 Replacement Volume and 2024 Supplement)  3 
 
 SECTION 1. BE IT ENACTED BY THE GENERAL ASSEMBLY OF MARYLAND, 4 
That the Laws of Maryland read as follows:  5 
 
Article – Insurance  6 
 
15–847. 7 
 
 (a) (1) In this section the following words have the meanings indicated.  8 
 
  (5) (i) “Specialty drug” means a prescription drug that:  9 
 
    1. is prescribed for an individual with a complex or chronic 10 
medical condition or a rare medical condition;  11 
 
    2. costs $600 or more for up to a 30 –day supply;  12 
 
    3. is not typically stocked at retail pharmacies; and  13 
 
    4. A. requires a difficult or unusual process of delivery to 14 
the patient in the preparation, handling, storage, inventory, or distribution of the drug; or  15 
 
    B. requires enhanced patient education, management, or 16 
support, beyond those required for traditional dispensing, before or after administration of 17 
the drug.  18 
 
   (ii) “Specialty drug” does not include a prescription drug prescribed 19 
to treat diabetes, HIV, or AIDS.  20 
 
 (d) Subject to SUBSECTION (H) OF THIS SECTION AND  § 15–805 of this subtitle 21 
[and], notwithstanding § 15 –806 of this subtitle, [nothing in ] AND EXCEPT AS PROVID ED 22 
IN § 15–847.2  OF THIS SUBTITLE , this article or regulations adopted under this article 23 
[precludes ] DO NOT PRECLUDE  an entity subject to this section from requiring a covered 24 
specialty drug to be obtained through:  25 
 
  (1) a designated pharmacy or other source authorized under the Health 26 
Occupations Article to dispense or administer prescription drugs; or  27 
 
  (2) a pharmacy participating in the entity’s provider network, if the entity 28 
determines that the pharmacy:  29 
 
   (i) meets the entity’s performance standards; and  30 
 
   (ii) accepts the ent ity’s network reimbursement rates.  31 
 HOUSE BILL 1243  3 
 
  
 (H) THIS SECTION MAY NOT BE CONSTRUED TO SUPE RSEDE THE AUTHORITY 1 
OF THE HEALTH SERVICES COST REVIEW COMMISSION TO SET RAT ES FOR 2 
SPECIALTY DRUGS ADMI NISTERED TO PATIENTS  IN A SETTING REGULAT ED BY THE 3 
HEALTH SERVICES COST  REVIEW COMMISSION .  4 
 
15–847.2.  5 
 
 (A) IN THIS SECTION , “SPECIALTY DRUG ” HAS THE MEANING STAT ED IN § 6 
15–847 OF THIS SUBTITLE . 7 
 
 (B) (1) THIS SECTION APPLIES TO: 8 
 
   (I) INSURERS AND NONPROF IT HEALTH SERVICE PL ANS THAT 9 
PROVIDE COVERAGE FOR  PRESCRIPTION DRUGS  UNDER INDIVIDUAL , GROUP , OR 10 
BLANKET HEALTH INSUR ANCE POLICIES OR CON TRACTS THAT ARE ISSU ED OR 11 
DELIVERED IN THE STATE ; AND 12 
 
   (II) HEALTH MAINTENANCE O RGANIZATIONS THAT PR OVIDE 13 
COVERAGE FOR PRESCRI PTION DRUGS UNDER IN DIVIDUAL OR GROUP CO NTRACTS 14 
THAT ARE I SSUED OR DELIVERED I N THE STATE . 15 
 
  (2) AN INSURER , A NONPROFIT HEALTH S ERVICE PLAN , OR A HEALTH 16 
MAINTENANCE ORGANIZA TION THAT PROVIDES C OVERAGE FOR PRESCRIP TION 17 
DRUGS THROUGH A PHAR MACY BENEFITS MANAGE R IS SUBJECT TO THE 18 
REQUIREMENTS OF THIS  SECTION . 19 
 
 (C) AN ENTITY SUBJECT TO THIS SECTION MAY NOT  EXCLUDE COVERAGE 20 
FOR A COVERED SPECIA LTY DRUG ADMINISTERE D OR DISPENSED BY A PROVIDER 21 
UNDER § 12–102 OF THE HEALTH OCCUPATIONS ARTICLE IF THE ENTITY  22 
DETERMINES THAT : 23 
 
  (1) THE PROVIDER THAT AD MINISTERS OR DISPENSES THE COVERE D 24 
SPECIALTY DRUG : 25 
 
   (I) IS AN IN –NETWORK PROVIDER OF COVERED MEDICAL  26 
ONCOLOGY SERVICES ; AND  27 
 
   (II) COMPLIES WITH STATE REGULATIONS FOR  THE 28 
ADMINISTERING AND DI SPENSING OF SPECIALT Y DRUGS ; AND 29 
 
  (2) THE COVERED SPECIALT Y DRUG IS : 30 
 
4 HOUSE BILL 1243   
 
    (I) INFUSED , AUTO–INJECTED , OR AN ORAL TARGETED 1 
IMMUNE MODULATOR ; OR 2 
 
   (II) AN ORAL MEDICATION T HAT: 3 
 
    1. REQUIRES COMPLEX DOS ING BASED ON CLINICA L 4 
PRESENTATION ; OR 5 
 
    2. IS USED CONCOMITANTL Y WITH OTHER INFUSIO N OR 6 
RADIATION THERAPIES . 7 
 
 (D) (1) THE SUBJECT TO SUBSECTION  (F) OF THIS SECTION , THE 8 
REIMBURSEMENT RATE F OR SPECIALTY DRUGS COVE RED UNDER THIS SECTI ON 9 
SHALL BE : 10 
 
  (1) (I) AGREED TO BY THE COV ERED , IN–NETWORK PROVIDER AND  11 
THE ENTITY SUBJECT T O THIS SECTION ; AND  12 
 
  (2) (II) BILLED AT A NONHOSPITAL LEVEL OF  CARE OR PLACE OF 13 
SERVICE . 14 
 
  (2) UNLESS OTHERWISE AGRE ED TO BY THE COVERED , IN–NETWORK 15 
PROVIDER AND THE ENT ITY SUBJECT TO THIS SECTION , THE REIMBURSEMENT RA TE 16 
FOR SPECIALTY DRUGS COVERED UNDER THIS S ECTION MAY NOT EXCEE D THE RATE 17 
APPLICABLE TO A DESI GNATED SPECIALTY PHA RMACY FOR DISPENSING  THE 18 
COVERED SPECIALTY DR UGS.  19 
 
 (E) THIS SECTION DOES NOT  PROHIBIT AN ENTITY S UBJECT TO THIS 20 
SECTION FROM REFUSIN G TO AUTHORIZE OR AP PROVE OR FROM DENYIN G 21 
COVERAGE FOR A COVER ED SPECIALTY DRUG ADMINISTERED OR DISP ENSED BY A 22 
PROVIDER IF ADMINIST ERING OR DISPENSING THE DRUG FAILS TO SA TISFY 23 
MEDICAL NECESSITY CR ITERIA . 24 
 
 (F) THIS SECTION MAY NOT BE CONSTRUED TO SUPE RSEDE THE AUTHORITY 25 
OF THE HEALTH SERVICES COST REVIEW COMMISSION TO SET RAT ES FOR 26 
SPECIALTY DRUGS ADMIN ISTERED TO PATIENTS IN A SETTING REGULAT ED BY THE 27 
HEALTH SERVICES COST REVIEW COMMISSION .  28 
 
15–1611.1.  29 
 
 (a) This section applies only to a pharmacy benefits manager that provides 30 
pharmacy benefits management services on behalf of a car rier. 31 
 
 HOUSE BILL 1243  5 
 
  (b) Except as provided in subsection (c) of this section, a pharmacy benefits 1 
manager may not require that a beneficiary use a specific pharmacy or entity to fill a 2 
prescription if:  3 
 
  (1) the pharmacy benefits manager or a corporate affiliate of t he pharmacy 4 
benefits manager has an ownership interest in the pharmacy or entity; or  5 
 
  (2) the pharmacy or entity has an ownership interest in the pharmacy 6 
benefits manager or a corporate affiliate of the pharmacy benefits manager.  7 
 
 (c) [A] EXCEPT AS PRO VIDED IN § 15–847.2  OF THIS TITLE , A pharmacy 8 
benefits manager may require a beneficiary to use a specific pharmacy or entity for a 9 
specialty drug as defined in § 15 –847 of this title.  10 
 
15–1612.  11 
 
 (a) This section applies only to a pharmacy benefits manage r that provides 12 
pharmacy benefits management services on behalf of a carrier.  13 
 
 (b) This section does not apply to reimbursement:  14 
 
  (1) EXCEPT AS PROVIDED I N § 15–847.2  OF THIS TITLE , for specialty 15 
drugs;  16 
 
  (2) for mail order drugs; or  17 
 
  (3) to a chain pharmacy with more than 15 stores or a pharmacist who is 18 
an employee of the chain pharmacy.  19 
 
 (c) A pharmacy benefits manager may not reimburse a pharmacy or pharmacist 20 
for a pharmaceutical product or pharmacist service in an amount less than the amount th at 21 
the pharmacy benefits manager reimburses itself or an affiliate for providing the same 22 
product or service.  23 
 
 SECTION 2. AND BE IT FURTHER ENACTED, That this Act shall apply to all 24 
policies, contracts, and health benefit plans issued, delivered, or renew ed in the State on or 25 
after January 1, 2026.  26 
 
 SECTION 3. AND BE IT FURTHER ENACTED, That this Act shall take effect 27 
January 1, 2026.  28 